Bruce I. Sachs - 06 Aug 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
06 Aug 2025
Net transactions value
+$1,948,416
Form type
4
Filing time
07 Aug 2025, 16:19:03 UTC
Previous filing
17 Jul 2025
Next filing
17 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SACHS BRUCE I Director C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 07 Aug 2025 0001197036

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Purchase $636,214 +1,634 +4.1% $389.36 41,634 06 Aug 2025 Direct F1, F2
transaction VRTX Common Stock Purchase $1,312,201 +3,366 +8.1% $389.84 45,000 06 Aug 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $389.36 (range $388.61 to $389.60).
F2 Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a weighted average price of $389.84 (range $389.61 to $390.00).